You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Patent: 3,933,996


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,933,996
Title: Composition comprising radioactive labeled-fibrinogen and albumin
Abstract:The stability of fibrinogen is improved by mixing it with albumin, preferably at least 5 parts by weight of albumin per part by weight of fibrinogen. By this invention, iodinated (.sup.125 I) human fibrinogen can be stabilised with human serum albumin for use in the diagnosis of thrombi.
Inventor(s): Charlton; John Cecil (Amersham, EN), Gravett; David Lawrence (Amersham, EN)
Assignee: The Radiochemical Centre Limited (Amersham, EN)
Application Number:05/371,529
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 3,933,996: A Comprehensive Review

Introduction

When delving into the world of patents, understanding the claims and the broader patent landscape is crucial for assessing the value, validity, and potential impact of a patent. This article will focus on the analysis of United States Patent 3,933,996, although the specific details of this patent are not provided in the sources. We will, however, use analogous examples and general principles to conduct a comprehensive and critical analysis.

Understanding Patent Claims

Patent claims are the heart of any patent application, defining the scope of the invention and what is protected by the patent. These claims must be clear, concise, and supported by the description and drawings provided in the patent application[3].

Types of Claims

  • Independent Claims: These stand alone and define the invention without reference to other claims.
  • Dependent Claims: These refer back to and further limit an independent claim.
  • Method Claims: Describe a process or method.
  • Apparatus Claims: Describe a device or system.
  • Composition Claims: Describe a mixture or compound[3].

The Importance of Claim Construction

Claim construction is the process of interpreting the meaning of the claims in a patent. This is critical because it determines the scope of protection and can significantly impact patent litigation. The courts use various tools, including the patent specification, prosecution history, and extrinsic evidence, to construe the claims[4].

Patent Landscape Analysis

Patent landscape analysis provides a snapshot of the innovation happening in a particular technological field. It helps in understanding where technology is heading, who the key players are, and where innovation is concentrated.

Identifying Key Players and Competitors

Using tools like PatentSight, analysts can identify competitors and allies by analyzing patent filing trends and the strength of patent portfolios. This involves evaluating the Competitive Impact of patents, which considers citations, geographic protection, and market size[3].

Evaluating Patent Trends

Global patent records can be analyzed to identify trends in patent filings, technological evolution, and market opportunities. This helps in developing international filing strategies and informing marketing decisions[3].

Case Study: Lexaria Bioscience Corp.

While the specific details of U.S. Patent 3,933,996 are not available, we can draw parallels from the patent activities of Lexaria Bioscience Corp. to illustrate key points.

DehydraTECH Technology

Lexaria Bioscience Corp. has developed DehydraTECH, a technology that enhances the delivery of bioactive molecules. The company has filed numerous patent applications and has been granted several patents related to this technology. This includes patents for the use of DehydraTECH with cannabinoids, nicotine, and nonsteroidal anti-inflammatory drugs[1][4].

Patent Filing Strategies

Lexaria's aggressive pursuit of patent protection in various jurisdictions highlights the importance of a robust patent filing strategy. The company has over 60 patent applications pending worldwide, with 17 patents granted to date. This approach ensures broad protection for their technology and positions them strongly in competitive markets[1][4].

Collaboration and Licensing

Lexaria's collaboration with companies like British American Tobacco (BAT) and their licensing agreements demonstrate how patent protection can facilitate partnerships and revenue generation. These partnerships are crucial for validating the technology and expanding its market reach[1].

Critical Analysis of Patent Strength

The strength of a patent is often measured by its Competitive Impact, which includes factors such as citation frequency, geographic protection, and market size. A patent with high Competitive Impact is more likely to be significant and influential in its field[3].

Citation Analysis

Citations from subsequent patents are a strong indicator of a patent's influence. Patents that are frequently cited are generally considered more valuable and impactful.

Geographic Protection

The geographic scope of a patent's protection is another critical factor. Patents protected in multiple territories, especially those with large markets, are typically more valuable.

Challenges and Risks

Unpredictability of Scientific Discovery

The development of new technologies and patent applications is inherently unpredictable. This unpredictability can lead to delays, cancellations, or significant changes in research plans[1].

Regulatory and Market Risks

Patent protection does not guarantee market success. Factors such as consumer acceptance, competition, and regulatory compliance can significantly impact the viability of a patented technology[1].

Key Takeaways

  • Clear and Concise Claims: The claims in a patent must be well-defined to ensure strong protection.
  • Comprehensive Patent Landscape Analysis: Understanding the broader patent landscape helps in identifying key players, trends, and opportunities.
  • Robust Patent Filing Strategies: Aggressive and strategic patent filing can provide broad protection and facilitate partnerships.
  • Collaboration and Licensing: Partnerships and licensing agreements can validate technology and generate revenue.
  • Evaluating Patent Strength: Factors like citation frequency, geographic protection, and market size are crucial for assessing a patent's impact.

FAQs

What is the purpose of patent claims in a patent application?

Patent claims define the scope of the invention and what is protected by the patent, ensuring that the inventor's rights are clearly outlined.

How is the strength of a patent evaluated?

The strength of a patent is often evaluated using metrics such as Competitive Impact, which considers factors like citation frequency, geographic protection, and market size.

Why is patent landscape analysis important?

Patent landscape analysis provides insights into innovation trends, key players, and market opportunities, helping companies to develop effective strategies and make informed decisions.

What are the risks associated with patent protection?

Despite strong patent protection, there are risks such as unpredictability in scientific discovery, regulatory challenges, and market competition that can impact the success of a patented technology.

How do companies like Lexaria Bioscience Corp. benefit from patent protection?

Companies like Lexaria benefit from patent protection through licensing agreements, partnerships, and the validation of their technology, which can lead to revenue generation and market expansion.

Sources

  1. Lexaria Bioscience Corp. - Prospectus: Registration No. 333­238915 PROSPECTUS.
  2. US20050095587A1 - Molecules for disease detection and treatment: Google Patents.
  3. Patent Landscape Analysis - LexisNexis IP: Understanding the evolution of a technology field.
  4. Annual Reports - Lexaria Bioscience Corp.: 2020 Annual Report.

More… ↓

⤷  Subscribe

Details for Patent 3,933,996

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Therapeutics Llc ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 albumin (human) For Injection 101138 October 21, 1942 ⤷  Subscribe 1993-01-20
Takeda Pharmaceuticals U.s.a., Inc. BUMINATE, FLEXBUMIN albumin (human) Injection 101452 March 03, 1954 ⤷  Subscribe 1993-01-20
Csl Behring Ag ALBURX albumin (human) Injection 102366 July 23, 1976 ⤷  Subscribe 1993-01-20
Grifols Biologicals Llc ALBUTEIN albumin (human) Injection 102478 August 15, 1978 ⤷  Subscribe 1993-01-20
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.